Kathleen McElhone

Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Richard B. Warren, Catherine Smith, Zenas Z N Yiu et al. · Journal of Investigative Dermatology · 2015 · 369 citations

Medicine, Clinical Sciences, Dermatology +9

Development and validation of a disease‐specific health‐related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus

Kathleen McElhone, Janice Abbott, J. Shelmerdine et al. · Arthritis Care & Research · 2007 · 342 citations · Full text

Pharmacy, Behavioral Sciences, Psychometrics +16

Psychological Distress Impairs Clearance of Psoriasis in Patients Treated With Photochemotherapy

Dónal G. Fortune, Helen L. Richards, Brian Kirby et al. · Archives of Dermatology · 2003 · 243 citations

Medicine, Dermatology, Psychology +13

HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis

Nick Dand, Michael Duckworth, David Baudry et al. · Journal of Allergy and Clinical Immunology · 2018 · 174 citations · Full text

Life Sciences, Genetics, Immunology +14

Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis

Zenas Z N Yiu, G Becher, Brian Kirby et al. · JAMA Dermatology · 2022 · 144 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15